Loading...

China's iKang announces acquisition of INLUNG

Image

22-Dec-15 iKang Healthcare Group, China's largest private preventive healthcare provider, announced it has acquired 70% interest of Xi'an iKang Health Management, which owns three medical centers under the brand name Xi'an INLUNG. This marks iKang's first steps into Xi'an, capital of Shaanxi Province. [image: Sapphire Healthcare]

Read More

Japan’s generics market woos Indian firms

Image

16-Nov-15 Japan, with sales of USD115, accounts for 10% of the global pharma market, compared with 38% for the US and 21% for Europe. Lupin is the only Indian company in Japan's generics market. But now Sun Pharmaceuticals is planning to acquire Novartis' Japanese drug portfolio. Other Indian generics makers, including Dr Reddy’s and Glenmark, are also exploring options. [image: Bloomberg]

Read More

Zimmer Biomet achieving synergies and rapid sales in Asia-Pacific

Image

03-Nov-15 In the first quarter after its merger, Zimmer Biomet has reported it expects to complete commercial integration by the end of 2015. It also reported progress on its sales channel integration, evidenced by sequential sales improvement in its Asia-Pacific and Europe, Middle East & Africa (EMEA) regions, where Knee orthopaedics sales increased 9% and 6% respectively. [image: Zimmer Biomet]

Read More